FDA Approves First-of-its-Kind Subcutaneous Infliximab Biosimilar

Press/Media

Period	1 Oct 2023

Media coverage

Title FDA Approves First-of-its-Kind Subcutaneous Infliximab Biosimilar
Media name/outlet Drug Topics (MJH)
Country/Territory United States
Date 1/10/23
Persons Jean-Frédéric Colombel

Title	FDA Approves First-of-its-Kind Subcutaneous Infliximab Biosimilar
Media name/outlet	Drug Topics (MJH)
Country/Territory	United States
Date	1/10/23
Persons	Jean-Frédéric Colombel